Literature DB >> 31845738

Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.

Joellen M Schildkraut.   

Abstract

In this issue of the American Journal of Epidemiology, Huang et al. (Am J Epidemiol. 2020;189(7):660-670) report an inverse relationship between lifetime ovulatory years (LOY) and circulating levels of C-reactive protein (CRP), counter to their hypothesis. CRP is a nonspecific systemic marker of chronic inflammation, and there is evidence that there are other drivers of systemic inflammation as measured by CRP. There also is a body of evidence supporting the possibility that ovulation may be responsible for a localized inflammatory response. Because ovarian cancer is the fifth most common cause of cancer death in women, preventive strategies are urgently needed. The findings of this report underscore the need for new research initiatives to determine the relationship between incessant ovulation and ovarian cancer risk in order to identify mechanisms of carcinogenesis.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  C-reactive protein; inflammation; inflammatory markers; lifetime ovulatory years; ovarian cancer; ovulation

Mesh:

Substances:

Year:  2020        PMID: 31845738      PMCID: PMC7393305          DOI: 10.1093/aje/kwz265

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Ovulation and risk of epithelial ovarian cancer.

Authors:  David M Purdie; Christopher J Bain; Victor Siskind; Penelope M Webb; Adèle C Green
Journal:  Int J Cancer       Date:  2003-03-20       Impact factor: 7.396

2.  Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.

Authors:  Kathryn L Terry; Linda Titus-Ernstoff; John R McKolanis; William R Welch; Olivera J Finn; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01       Impact factor: 4.254

Review 3.  The distal fallopian tube: a new model for pelvic serous carcinogenesis.

Authors:  Christopher P Crum; Ronny Drapkin; Alexander Miron; Tan A Ince; Michael Muto; David W Kindelberger; Yonghee Lee
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

Review 4.  The disparate origins of ovarian cancers: pathogenesis and prevention strategies.

Authors:  Anthony N Karnezis; Kathleen R Cho; C Blake Gilks; Celeste Leigh Pearce; David G Huntsman
Journal:  Nat Rev Cancer       Date:  2016-11-25       Impact factor: 60.716

5.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.

Authors:  D W Cramer; W R Welch
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

Review 6.  Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.

Authors:  Leo J Schouten; Christine Rivera; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Alan Arslan; W Lawrence Beeson; Piet A van den Brandt; Julie E Buring; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Susan E Hankinson; James V Lacey; Michael Leitzmann; Annekatrin Lukanova; James R Marshall; Anthony B Miller; Alpa V Patel; Carmen Rodriguez; Thomas E Rohan; Julie A Ross; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

7.  Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Authors:  Jennifer Ose; Helena Schock; Anne Tjønneland; Louise Hansen; Kim Overvad; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopolou; Vassiliki Benetou; Pagona Lagiou; Giovanna Masala; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H B As Bueno-de-Mesquita; Petra H M Peeters; N Charlotte Onland-Moret; Elisabete Weiderpass; Inger T Gram; Soledad Sánchez; Mireia Obon-Santacana; Maria-José Sànchez-Pérez; Nerea Larrañaga; José María Huerta Castaño; Eva Ardanaz; Jenny Brändstedt; Eva Lundin; Annika Idahl; Ruth C Travis; Kay-Tee Khaw; Sabina Rinaldi; Isabelle Romieu; Melissa A Merritt; Marc J Gunter; Elio Riboli; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-08       Impact factor: 4.254

8.  The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.

Authors:  Hagen Kulbe; Richard Thompson; Julia L Wilson; Stephen Robinson; Thorsten Hagemann; Rewas Fatah; David Gould; Ayse Ayhan; Frances Balkwill
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

Review 9.  The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer.

Authors:  Sudha S Savant; Shruthi Sriramkumar; Heather M O'Hagan
Journal:  Cancers (Basel)       Date:  2018-07-30       Impact factor: 6.639

10.  A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Authors:  Peter M Scarbrough; Rachel Palmieri Weber; Edwin S Iversen; Yonathan Brhane; Christopher I Amos; Peter Kraft; Rayjean J Hung; Thomas A Sellers; John S Witte; Paul Pharoah; Brian E Henderson; Stephen B Gruber; David J Hunter; Judy E Garber; Amit D Joshi; Kevin McDonnell; Doug F Easton; Ros Eeles; Zsofia Kote-Jarai; Kenneth Muir; Jennifer A Doherty; Joellen M Schildkraut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-04       Impact factor: 4.254

View more
  1 in total

1.  Huang et al. Respond to "Ovulation and Systemic and Localized Inflammation Markers" and "Capturing Women's Reproductive Life Spans".

Authors:  Tianyi Huang; Amy L Shafrir; A Heather Eliassen; Kathryn M Rexrode; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.